Beranda › Limfoma Sel B Besar Difus › Utah › Salt Lake City
Uji klinis Limfoma Sel B Besar Difus di Salt Lake City, UT
12 studi untuk Limfoma Sel B Besar Difus mencari peserta di lokasi sekitar Salt Lake City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Menerima pesertaFase 2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
- Intermountain Health LDS Hospital, Salt Lake City
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Menerima pesertaFase 1
- Intermountain Healthcare, Salt Lake City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Menerima pesertaFase 1/2
- Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
Menerima pesertaFase 1
- Huntsman Cancer Institute, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Menerima pesertaFase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Menerima pesertaFase 3
- Intermountain Healthcare, Salt Lake City
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL
Menerima pesertaFase 1
- Huntsman Cancer Institute at University of Utah, Salt Lake City
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Menerima pesertaFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Menerima pesertaFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Menerima pesertaFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Menerima pesertaFase 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Uji klinis Limfoma Sel B Besar Difus di kota lain
- New York City, NY21 studi
- Baldwin Park, CA19 studi
- Chicago, IL18 studi
- Los Angeles, CA17 studi
- Houston, TX17 studi
- Boston, MA16 studi
- Milwaukee, WI16 studi
- Portland, OR15 studi
- Nashville, TN15 studi
- Philadelphia, PA15 studi
- Durham, NC14 studi
- Dallas, TX13 studi
Studi lain di Salt Lake City
- Kanker Paru Non-Sel Kecil31 studi
- Kanker (semua jenis)27 studi
- Kanker Payudara27 studi
- Kanker Kolorektal21 studi
- Kanker Paru21 studi
- Mieloma Multipel21 studi
- Melanoma21 studi
- Kanker Metastatik20 studi
- Kanker Ovarium19 studi
- Obesitas18 studi
- Leukemia Mieloid Akut17 studi
- Gagal Jantung17 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.